McN-4612 is a noradrenaline-preferring serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) developed by McNeil Laboratories in the 1980s. == Pharmacology == Binding affinities (Ki) are reported to be the following (nM): As can be seen nearly all of the Ki activity resides in a single optical antipode (or enantiomer).
McN-4612 is a noradrenaline-preferring serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) developed by McNeil Laboratories in the 1980s. == Pharmacology == Binding affinities (Ki) are reported to be the following (nM): As can be seen nearly all of the Ki activity resides in a single optical antipode (or enantiomer).
Source: Wikipedia "McN-4612" · CC BY-SA 4.0
Share this article: X · Bluesky